Contra-indicated in patients with undiagnosed abnormal vaginal bleeding.
[C] = Children.
- TRADE NAME: Synarel (Pfizer)
- INDICATIONS: Endometriosis, control of precocious puberty
- CLASS: Gonadotropin-releasing hormone (GnRH) agonist
- HALF-LIFE: ~3 hours
- CLINICALLY IMPORTANT, POTENTIALLY HAZARDOUS INTERACTIONS WITH:
None known
- See adverse reactions attributed to class:
Please login to view the rest of this drug profile.
Page last updated 07/31/2023
